Shogen Boku

Lecturer

Osaka University Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shogen Boku is a Lecturer at Kansai Medical University Hospital in Japan. His research interests encompass various aspects of oncology, including the efficacy of immunotherapies and targeted treatments for advanced cancers, as demonstrated in his recent articles. He has notably contributed to studies on gastric cancer, head and neck squamous cell carcinoma, and the impact of the gut microbiome on cancer treatment outcomes.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (9)

Nobuhiro Shibata

Lecturer

Kansai Medical University

JAPAN

View details

Sohei Satoi

Kansai Medical University

JAPAN

View details

Tomohisa Yamamoto

Kansai Medical University

JAPAN

View details

Takayasu Kurata

JAPAN

View details

Motoki Watanabe

Kyoto University

JAPAN

View details

Tatsuki Ikoma

Kobe University Hospital

JAPAN

View details

Hidekazu Hirano

Keio University School of Medicine

JAPAN

View details

Mitsugu Sekimoto

Kansai Medical University

JAPAN

View details

Daisuke Hashimoto

Kansai Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shogen Boku

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Trametinib Suppresses the Stimulated T Cells Through G1 Arrest and Apoptosis.

Relationship between the effectiveness of pembrolizumab monotherapy and ABO blood type in recurrent and metastatic squamous cell carcinoma of the head and neck

ONO‐4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer

Resistance mechanism to pembrolizumab in DEK-AFF2 fusion-associated sinonasal squamous cell carcinoma

Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer

Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A)

A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer

Survival impact of occult liver metastasis and peritoneal dissemination compared with radiologically defined distant organ metastasis in pancreatic ductal adenocarcinoma

Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy

TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III <i>BRAF</i> V600E-mutated colorectal cancer

Collaborators (9)

Nobuhiro Shibata

Sohei Satoi

Tomohisa Yamamoto

Takayasu Kurata

Motoki Watanabe

Tatsuki Ikoma

Hidekazu Hirano

Mitsugu Sekimoto

Daisuke Hashimoto

Make your next move.